Strengthening the U.S. Pharmaceutical Supply Ch...

By João L. Carapinha

August 15, 2025

The recent White House executive action introduces the establishment of a Strategic Active Pharmaceutical Ingredients (API) Reserve. This aims to bolster the resilience of the U.S. Pharmaceutical Supply Chain. The directive mandates federal suppor...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...
FDA Approved Eye Drops: Lenz Therapeutics Launches VIZZ for Presbyopia Treatment
Enhancing Benefit Assessments: Insights from IQWiG Real-World Data Report
Donanemab Alzheimer’s Approval: A New Era in Treatment
Building a Better Ecosystem for Digitally Enabled Diabetes Care in Europe
AI in Real-World Evidence: Insights from Mitch Higashi
Achieving International Drug Price Parity: Trump’s Mandate
NICE’s 2025 Guidance on Obesity Management Support
Enhancing Patient Involvement in EU JCAs